SI1181290T1 - Polymorphs of a crystalline azabicyclo (2,2,2) octan-3-amine citrate and their pharmaceutical compositions - Google Patents

Polymorphs of a crystalline azabicyclo (2,2,2) octan-3-amine citrate and their pharmaceutical compositions

Info

Publication number
SI1181290T1
SI1181290T1 SI200030161T SI200030161T SI1181290T1 SI 1181290 T1 SI1181290 T1 SI 1181290T1 SI 200030161 T SI200030161 T SI 200030161T SI 200030161 T SI200030161 T SI 200030161T SI 1181290 T1 SI1181290 T1 SI 1181290T1
Authority
SI
Slovenia
Prior art keywords
octan
polymorphs
pharmaceutical compositions
amine citrate
azabicyclo
Prior art date
Application number
SI200030161T
Other languages
English (en)
Slovenian (sl)
Inventor
Michael James Castaldi
George Joseph Quallich
Lewin Theophilus Wint
Original Assignee
Pfizer Products Inc.
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Pfizer Products Inc. filed Critical Pfizer Products Inc.
Publication of SI1181290T1 publication Critical patent/SI1181290T1/xx

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D453/00—Heterocyclic compounds containing quinuclidine or iso-quinuclidine ring systems, e.g. quinine alkaloids
    • C07D453/02—Heterocyclic compounds containing quinuclidine or iso-quinuclidine ring systems, e.g. quinine alkaloids containing not further condensed quinuclidine ring systems
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P1/00—Drugs for disorders of the alimentary tract or the digestive system
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P1/00—Drugs for disorders of the alimentary tract or the digestive system
    • A61P1/08—Drugs for disorders of the alimentary tract or the digestive system for nausea, cinetosis or vertigo; Antiemetics

Landscapes

  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • General Health & Medical Sciences (AREA)
  • General Chemical & Material Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Engineering & Computer Science (AREA)
  • Animal Behavior & Ethology (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Hospice & Palliative Care (AREA)
  • Otolaryngology (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Medicinal Preparation (AREA)
  • Nitrogen Condensed Heterocyclic Rings (AREA)
  • Organic Low-Molecular-Weight Compounds And Preparation Thereof (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
SI200030161T 1999-06-01 2000-05-18 Polymorphs of a crystalline azabicyclo (2,2,2) octan-3-amine citrate and their pharmaceutical compositions SI1181290T1 (en)

Applications Claiming Priority (3)

Application Number Priority Date Filing Date Title
US13699299P 1999-06-01 1999-06-01
EP00925528A EP1181290B1 (en) 1999-06-01 2000-05-18 Polymorphs of a crystalline azabicyclo (2,2,2) octan-3-amine citrate and their pharmaceutical compositions
PCT/IB2000/000665 WO2000073304A1 (en) 1999-06-01 2000-05-18 Polymorphs of a crystalline azabicyclo (2,2,2) octan-3-amine citrate and their pharmaceutical compositions

Publications (1)

Publication Number Publication Date
SI1181290T1 true SI1181290T1 (en) 2003-12-31

Family

ID=22475338

Family Applications (1)

Application Number Title Priority Date Filing Date
SI200030161T SI1181290T1 (en) 1999-06-01 2000-05-18 Polymorphs of a crystalline azabicyclo (2,2,2) octan-3-amine citrate and their pharmaceutical compositions

Country Status (49)

Country Link
US (1) US6255320B1 (xx)
EP (1) EP1181290B1 (xx)
JP (1) JP3830816B2 (xx)
KR (1) KR100476606B1 (xx)
CN (1) CN1146565C (xx)
AP (1) AP2001002349A0 (xx)
AR (1) AR033331A1 (xx)
AT (1) ATE244239T1 (xx)
AU (1) AU767334B2 (xx)
BG (1) BG65240B1 (xx)
BR (1) BR0011094A (xx)
CA (1) CA2372238C (xx)
CO (1) CO5170463A1 (xx)
CY (1) CY2007011I2 (xx)
CZ (1) CZ295819B6 (xx)
DE (1) DE60003679T2 (xx)
DK (1) DK1181290T3 (xx)
DZ (1) DZ3050A1 (xx)
EA (1) EA003731B1 (xx)
EC (1) ECSP003508A (xx)
EE (1) EE200100656A (xx)
ES (1) ES2199825T3 (xx)
GT (1) GT200000087A (xx)
HK (1) HK1046284A1 (xx)
HN (1) HN2000000077A (xx)
HR (1) HRP20010904A2 (xx)
HU (1) HUP0201301A3 (xx)
IL (1) IL146406A0 (xx)
MA (1) MA26742A1 (xx)
MX (1) MXPA01012325A (xx)
MY (1) MY133508A (xx)
NO (1) NO20015848L (xx)
NZ (1) NZ515349A (xx)
OA (1) OA11956A (xx)
PA (1) PA8496101A1 (xx)
PE (1) PE20010209A1 (xx)
PL (1) PL196046B1 (xx)
PT (1) PT1181290E (xx)
SI (1) SI1181290T1 (xx)
SK (1) SK285820B6 (xx)
SV (1) SV2001000093A (xx)
TN (1) TNSN00120A1 (xx)
TR (1) TR200103473T2 (xx)
TW (1) TWI285204B (xx)
UA (1) UA66925C2 (xx)
UY (1) UY26176A1 (xx)
WO (1) WO2000073304A1 (xx)
YU (1) YU81101A (xx)
ZA (1) ZA200109775B (xx)

Families Citing this family (7)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
RU2337685C2 (ru) 2004-01-30 2008-11-10 Пфайзер Продактс Инк. Антагонисты нейрокининового рецептора nk-1 для выхода из наркоза
AU2005216707A1 (en) * 2004-01-30 2005-09-09 Pfizer Products Inc. Pharmaceutical compositions of neurokinin receptor antagonists and cyclodextrin and methods for improved injection site toleration
US8183230B2 (en) * 2004-01-30 2012-05-22 Pfizer Inc. Antimicrobial preservatives to achieve multi-dose formulation using beta-cyclodextrins for liquid dosage forms
ES2296131T3 (es) * 2004-02-02 2008-04-16 Pfizer Products Incorporated Procedimiento para la preparacion de 1-(2s,3s)-2-bencidril-n-(5-terc-butil-2-metoxibencil)quinuclidin-3-amina.
MX361286B (es) * 2013-03-15 2018-12-03 Pearl Therapeutics Inc Métodos y sistemas para el acondicionamiento de materiales cristalinos de partículas.
CN110577522B (zh) * 2018-06-07 2022-12-27 东莞市东阳光动物保健药品有限公司 马罗匹坦柠檬酸盐新晶型及其制备方法
CN112979639A (zh) * 2019-12-16 2021-06-18 四川科瑞德凯华制药有限公司 一种马罗皮坦新晶型及其制备方法

Family Cites Families (3)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
SK390692A3 (en) * 1991-05-31 1998-02-04 Pfizer Quinuclidine derivatives, preparation method thereof and use
US5393762A (en) * 1993-06-04 1995-02-28 Pfizer Inc. Pharmaceutical agents for treatment of emesis
US5576317A (en) * 1994-12-09 1996-11-19 Pfizer Inc. NK-1 receptor antagonists and 5HT3 receptor antagonists for the treatment of emesis

Also Published As

Publication number Publication date
PL196046B1 (pl) 2007-11-30
PT1181290E (pt) 2003-09-30
EE200100656A (et) 2003-02-17
UA66925C2 (uk) 2004-06-15
DK1181290T3 (da) 2003-09-29
CY2007011I1 (el) 2010-07-28
EP1181290B1 (en) 2003-07-02
SK17332001A3 (sk) 2002-07-02
SK285820B6 (sk) 2007-09-06
EA003731B1 (ru) 2003-08-28
ZA200109775B (en) 2002-11-28
GT200000087A (es) 2001-11-22
NO20015848D0 (no) 2001-11-30
PL352716A1 (en) 2003-09-08
HUP0201301A2 (en) 2002-08-28
PA8496101A1 (es) 2002-07-30
MY133508A (en) 2007-11-30
CA2372238A1 (en) 2000-12-07
CZ295819B6 (cs) 2005-11-16
OA11956A (en) 2006-04-13
CA2372238C (en) 2006-12-19
AR033331A1 (es) 2003-12-17
ES2199825T3 (es) 2004-03-01
PE20010209A1 (es) 2001-03-01
TNSN00120A1 (fr) 2005-11-10
HK1046284A1 (en) 2003-01-03
DE60003679T2 (de) 2004-05-27
ATE244239T1 (de) 2003-07-15
CY2007011I2 (el) 2010-07-28
HRP20010904A2 (en) 2003-02-28
ECSP003508A (es) 2002-02-25
SV2001000093A (es) 2001-11-08
BG106204A (en) 2002-07-31
DE60003679D1 (de) 2003-08-07
NO20015848L (no) 2001-12-18
US6255320B1 (en) 2001-07-03
CZ20014269A3 (cs) 2002-04-17
MXPA01012325A (es) 2002-07-22
BG65240B1 (bg) 2007-09-28
EP1181290A1 (en) 2002-02-27
BR0011094A (pt) 2002-03-19
KR20020010688A (ko) 2002-02-04
AP2001002349A0 (en) 2001-12-31
HUP0201301A3 (en) 2002-10-28
UY26176A1 (es) 2000-12-29
HN2000000077A (es) 2001-02-02
YU81101A (sh) 2004-07-15
DZ3050A1 (fr) 2004-03-27
KR100476606B1 (ko) 2005-03-18
NZ515349A (en) 2004-03-26
IL146406A0 (en) 2002-07-25
CO5170463A1 (es) 2002-06-27
CN1353711A (zh) 2002-06-12
CN1146565C (zh) 2004-04-21
TR200103473T2 (tr) 2002-04-22
EA200101108A1 (ru) 2002-04-25
WO2000073304A1 (en) 2000-12-07
MA26742A1 (fr) 2004-12-20
AU4424800A (en) 2000-12-18
JP3830816B2 (ja) 2006-10-11
JP2003501354A (ja) 2003-01-14
AU767334B2 (en) 2003-11-06
TWI285204B (en) 2007-08-11

Similar Documents

Publication Publication Date Title
HUP0202100A2 (en) Novel quinuclidine derivatives, process for their preparation and medicinal compositions containing the same
HUP0201376A2 (en) Thiazoloderivatives and pharmaceutical compositions containing them and process for preparation the compounds
HUP0203542A3 (en) 3(5)-amino-pyrazole derivatives, process for their preparation, their use and pharmaceutical compositions containing the same
HUP9903377A3 (en) The mesylate salt of a macrocyclic bis-indolyl-maleimide derivative, process for its preparation, use thereof and pharmaceutical compositions containing the compound
HUP0303524A3 (en) Novel quinuclidine derivatives, process for their preparation and medicinal compositions containing the same and their use
HUP0203514A3 (en) Quinuclidine compounds and drugs containing them and process for preparation the same
HUP0002843A3 (en) New betha-carboline compounds, a process for their preparation and pharmaceutical compositions containing them
IL146434A0 (en) Pharmaceutical compositions containing ecteinascidin 743
AU2001258677A1 (en) Novel compounds having antiinflammatory activity: process for their preparation and pharmaceutical compositions containing them
HUP0202255A3 (en) Crystalline 1-methylcarbapenem compounds and pharmaceutical compositions containing them
HUP0101043A3 (en) Controlled release oral dosage form containing [r-(z)]-alpha-(methoxyimino)-alpha-(1-azabicyclo[2.2.2]oct-3-yl]acetonitrile monohydrochlorid and process for its preparation
HUP0200669A3 (en) Process for producing pharmaceutical preparation for oral administration containing tolperison
HUP0001961A3 (en) Substituted dimeric compounds, a process for their preparation and pharmaceutical compositions contaning them
HUP0203471A3 (en) Antithrombotic compound, process for their preparation, pharmaceutical compositions containing them and their use
PL352716A1 (en) Polymorphs of a crystalline azabicyclo (2,2,2) octan-3-amine citrate and their pharmaceutical compositions
HUP0201667A2 (en) Oral form of administration
HUP0004573A3 (en) New camptothecin analogue compounds, a process for their preparation and pharmaceutical compositions containing them
HUP0001712A2 (en) 2,3-methano-amino acid derivatives, a process for their preparation and pharmaceutical compositions containing them
PL345309A1 (en) Benzofuran derivatives, pharmaceutical composition containing the same, and a process for the preparation of the active ingredient
AU7773900A (en) Novel c13-substituted estra-1,3,5(10)-triene-3-yl-sulfamates, a method for producing the same and pharmaceutical compositions containing these compounds
HUP0200187A3 (en) A process for the preparation of 1,4,7,10-tetraazacyclododecane
HUP0002277A3 (en) Bicyclic amino-pyrazinone compounds, a process for their preparation and pharmaceutical compositions containing them
HUP0004543A3 (en) Aminopyrroline compounds, process for their preparation and pharmaceutical compositions containing them
HUP0201321A3 (en) New betha-amide and betha-sulfonamide carboxylic acid derivatives, their preparation and pharmaceutical compositions containing the compounds
ZA993477B (en) Polymorphs of a crystalline pyrazine-monohydrochloride and their pharmaceutical compositions.